About

Publications While At HealthPartners

selected publications

Journal Article

Weight loss, glycemic control, and cardiovascular disease risk factors in response to differential diet composition in a weight loss program in type 2 diabetes: a randomized controlled trial. 

Diabetes care. 2014

DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide. 

Diabetic Medicine. 2011

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. 

Lancet (London, England). 2008

Review

Exenatide once weekly for the treatment of type 2 diabetes [review]. 

Expert opinion on investigational drugs. 2009

Abstract

Weight loss and metabolic response to a commercial weight loss program in type 2 diabetes [abstract]. 

Diabetes. 2013

Contact

full name

K. S. Taylor

Quick Info

 

Collaboration

Co-author network

Map of science